Electromed Q3 revenue hits record, beating estimates driven by strong homecare market

Electromed

12/05/2026 21:21

Overview

U.S. airway clearance device maker's fiscal Q3 revenue rose 18.4%, beating analyst expectations

Net income for fiscal Q3 rose 59% and beat analyst expectations

Growth driven by higher sales rep productivity and increased homecare market demand

Outlook

Electromed says it is confident in sustaining its trajectory of profitable growth

Result Drivers

SALES FORCE EXPANSION - Growth in direct homecare revenue was driven by an increase in direct sales representatives and higher productivity per representative

HOMECARE MARKET DEMAND - Direct homecare business revenue rose 18.6%, reflecting strong demand in the core market

HIGHER NET REVENUE PER DEVICE - Gross profit and margin gains were attributed to increased overall revenue and higher net revenues per device

Company press release: ID:nBw20C4Hza

Key Details

Metric
Beat/Miss
Actual
Consensus Estimate
Q3 Revenue
Beat
$18.6 mln
$17.52 mln (4 Analysts)
Q3 EPS
$0.35
Q3 Net Income
Beat
$3 mln
$2.13 mln (4 Analysts)
Q3 Operating Income
$3.8 mln


Analyst Coverage

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 4 "strong buy" or "buy", no "hold" and no "sell" or "strong sell"

The average consensus recommendation for the advanced medical equipment & technology peer group is "buy"

Wall Street's median 12-month price target for Electromed Inc is $36.00, about 38.8% above its May 11 closing price of $25.93

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)